Suppr超能文献

利尿剂与系统性高血压的治疗

Diuretics and the treatment of systemic hypertension.

作者信息

Aranda P, Lopez de Novales E

机构信息

Hypertension Unit, Regional Hospital, Malaga, Spain.

出版信息

Am J Cardiol. 1990 May 2;65(17):72H-76H. doi: 10.1016/0002-9149(90)90348-5.

Abstract

Diuretics are still among the most frequently used antihypertensive drugs in the treatment of hypertension. Their pharmacologic and hemodynamic properties are based on the water and salt metabolism in the pathophysiology of high blood pressure. Initially, there is a reduction of plasma and extracellular fluid volume; cardiac output also decreases. After this early phase, cardiac output returns to normal with an accompanying decrease in peripheral resistance so as to correct the underlying hemodynamic fault of the hypertensive state. Diuretics have a high therapeutic efficacy either as monotherapy or in combination with beta blockers, angiotensin-converting enzyme inhibitors or calcium antagonists. The main problem with the use of diuretics is related to their metabolic side effects, which are dose-related. Currently, there is a tendency to administer low-dose diuretics, which result in fewer clinical and metabolic side effects, but with a continued antihypertensive efficacy. Therefore, low doses of diuretics can be recommended as initial therapy in the stepped-care approach of hypertension.

摘要

利尿剂仍然是治疗高血压最常用的抗高血压药物之一。它们的药理和血流动力学特性基于高血压病理生理学中的水盐代谢。最初,血浆和细胞外液量减少;心输出量也降低。在这个早期阶段之后,心输出量恢复正常,同时外周阻力降低,以纠正高血压状态下潜在的血流动力学异常。利尿剂作为单一疗法或与β受体阻滞剂、血管紧张素转换酶抑制剂或钙拮抗剂联合使用时具有很高的治疗效果。使用利尿剂的主要问题与其代谢副作用有关,这些副作用与剂量相关。目前,倾向于使用低剂量利尿剂,其临床和代谢副作用较少,但仍具有持续的抗高血压疗效。因此,在高血压的阶梯式治疗方法中,低剂量利尿剂可作为初始治疗推荐。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验